The
Global
Malaria Vaccines Market
is
pegged to be valued at US$ 8.5 million in 2018 and is projected to
expand at a CAGR of 102.8% during the forecast period (2018-2024), as
highlighted in a new report published by Coherent Market
Insights.Rise
in demand for vaccines for important indications on the backdrop of
increasing focus on biological preparations is expected to be a major
factor driving growth of the global malaria vaccines market over the
foreseeable future.
According to World Health Organization (WHO)
malaria fact sheet and World Bank estimates, over 40% of the global
population is at risk of malaria. World Health Organization (WHO),
there were around 214 million malaria cases reported in 2015, leading
to 438,000 deaths worldwide. Over 70% of these deaths were among
children under 5 years of age. Sub-Saharan Africa accounts for the
highest share of global malaria burden, with around 89% of malaria
cases and 91% of malarial deaths in 2015. Such high impact of this
life-threatening disease is influencing governments across various
countries, companies, investors, and non-profit organizations to
contribute towards curbing spreading of this disease. Since the
problem of malaria is burdening many of the emerging and under
developed regions such as in Africa and Asia Pacific, various
initiatives have been implemented in these regions to drive down high
costs of the vaccine in development. For instance, in 2016, GSK
announced plans to develop vaccines at a mere profit margin of 5% of
the cost of the vaccine. Governments across most regions are actively
involved in programs aimed at eliminating malaria. For instance, WHO
had mobilized funding for pilot program in first phase between 2017
and 2020 by the global fund to fight against malaria and other
disease such as AIDS and tuberculosis prevalent worldwide.
Request
Sample of Malaria Vaccines Market:
https://www.coherentmarketinsights.com/insight/request-sample/37
Shift from pharmaceutical oral dosage forms to
parenteral dosage forms is expected boost the malaria vaccines market
globally. The emerging economies are undergoing a wave of various
healthcare reforms. Healthcare treatment regimens are becoming more
reliable for the growth of the global market, with various
initiatives in place to eradicate the menace of malaria. In 2016, in
India, the National Framework for Malaria Elimination (NFME), was
launched to eliminate the problem in the country. This program was
based on the Framework by the National Vector Borne Disease Control
Program (NVBDCP) of the Ministry of Health and Family Welfare.
According to NFME, in 2012, the total economic burden of malaria in
India was around US$ 1,940 Mn, with 75% from lost earnings and 25%
from treatment costs borne by households.
According to World Malaria Report 2015, India
accounts for around 70% of the total malaria incidence rate in the
South-East Asia. In 2014, the incidence rate of malaria in the
country was around 0.89 per 1,000 person at risk per year. Around
1.1 Mn cases were reported, which lead to 562 deaths in India in
2014.
To Get Discount
On This
Report:https://www.coherentmarketinsights.com/insight/request-discount/37
Key takeaways of the malaria vaccines
market:
The global malaria vaccines market is expected to
expand at a CAGR of 102.8% during the forecast period (2016–2024)
as there exists a large unrealized market especially in Africa, Asia
Pacific, Latin America and Middle EastThe Pre-Erythrocytic Vaccine
dominates the market in the vaccines type segment, as it is used to
prevent the infection completely, while blood-stage vaccines aim to
reduce or eliminate the parasite load once a person is infected
Plasmodium Falciparum is the major agent segment
of malaria vaccines market, as Plasmodium falciparum infection are
induced by the asexual stages of the parasite that develop inside red
blood cells, making it one of most severe forms of malaria among
various types of parasites causing malaria
Some of the major players involved in global
malaria vaccines market are GlaxoSmithKline plc, Sanaria Inc,
Nobelpharma Co., Ltd., Sumaya Biotech and GenVec, Inc.
Check
The Trending Report of Malaria Vaccines Market:
https://www.coherentmarketinsights.com/market-insight/malaria-vaccines-market-37
About Coherent Market Insights:
Coherent Market Insights is a prominent market
research and consulting firm offering action-ready syndicated
research reports, custom market analysis, consulting services, and
competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave,
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Visit Blog
: http://globalresearchtrends.blogspot.in/
No comments:
Post a Comment